Baricitinib effective in cutaneous manifestations of dermatomyositis Dr Manoj Kumar Nayak30 Dec 2022 4:15 AM GMTBaricitinibeffective in cutaneous manifestations of dermatomyositisDermatomyositis(DM) is a rare autoimmune collagen vascular disease with cutaneous...
FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 3:30 AM GMTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
Treating sarcoidosis with JAK inhibitor shows promise in clinical trial Dr. Kamal Kant Kohli12 Jun 2022 2:00 PM GMTEvery patient in a Yale clinical trial of a new treatment for the disfiguring disease sarcoidosis saw improvement to their skin-and more than half...
Medical Bulletin 29/December/2021 Dr. Nandita Mohan29 Dec 2021 1:02 PM GMTHere are Top Medical stories of the dayViagra use linked to reduced risk of Alzheimer's diseaseA new Cleveland Clinic-led study has identified...
Barcitinib effective in severe nail lichen planus- 1st case report Dr Manoj Kumar Nayak23 Dec 2021 3:30 AM GMTBarcitinib effective in severe nail lichen planus- 1st case report - Lichen planus (LP) is an inflammatory disorder of the skin and mucous...
Tofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Dr Manoj Kumar Nayak15 Sep 2021 4:00 AM GMTTofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Alopecia areata is a common disorder of hair loss, treatment of...
Upadacitinib monotherapy alone may improve RA significantly Dr. Kamal Kant Kohli12 July 2020 1:23 PM GMTResearchers have found in a clinical trial of patients with rheumatoid arthritis that JAK inhibitor upadacitinib may lead to significant improvements...
